Literature DB >> 20858975

HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease.

Francisco J Gil-Bea1, Barbara Aisa, Alina Solomon, Maite Solas, Maria del Carmen Mugueta, Bengt Winblad, Miia Kivipelto, Angel Cedazo-Mínguez, María J Ramírez.   

Abstract

The present work investigated the involvement of cortisol and its receptors, glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), in Alzheimer's disease (AD). Cortisol was measured in cerebrospinal fluid (CSF) samples from controls, mild cognitive impairment (MCI), progressive MCI evolving to AD, and AD. CSF cortisol levels do not seem to have a prognostic value, as increases in cortisol levels were found only in AD patients. GR expression was decreased while MR expression was increased in the frontal cortex of AD. When considering degeneration (ratio to synaptophysin and the post-synaptic marker PSD95), GR expression was similar between controls and AD, suggesting that GR loss was due to synaptic degeneration in AD. Increases in cortisol levels and MR expression were associated to an apolipoprotein E4 genotype. Cognitive status was negatively associated to CSF cortisol. In apolipoprotein E4 carriers, MR but not GR expression, negatively correlated to Mini-Mental Status Examination score and positively correlated to frontal cortex amyloid-β levels. It is concluded that there is a dysregulation of the hypothalamus-pituitary-adrenal axis in AD that seems to be consequence rather than cause of AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858975     DOI: 10.3233/JAD-2010-100663

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

1.  ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations.

Authors:  Lance A Johnson; Damian G Zuloaga; Erin Bidiman; Tessa Marzulla; Sydney Weber; Helane Wahbeh; Jacob Raber
Journal:  Neuropsychopharmacology       Date:  2015-05-10       Impact factor: 7.853

2.  MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia.

Authors:  Astrid Vallès; Gerard J M Martens; Peter De Weerd; Geert Poelmans; Armaz Aschrafi
Journal:  J Psychiatry Neurosci       Date:  2014-09       Impact factor: 6.186

3.  Apolipoprotein E gene polymorphism, trauma burden, and posttraumatic stress symptoms in U.S. military veterans: Results from the National Health and Resilience in Veterans Study.

Authors:  Natalie P Mota; Shizhong Han; Ilan Harpaz-Rotem; Paul Maruff; John H Krystal; Steven M Southwick; Joel Gelernter; Robert H Pietrzak
Journal:  Depress Anxiety       Date:  2017-11-24       Impact factor: 6.505

4.  Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers.

Authors:  A Briones; S Gagno; E Martisova; M Dobarro; B Aisa; M Solas; R Tordera; Mj Ramírez
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  Stress and Alzheimer's disease.

Authors:  Claus M Escher; Lena Sannemann; Frank Jessen
Journal:  J Neural Transm (Vienna)       Date:  2019-02-20       Impact factor: 3.575

6.  Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E.

Authors:  Shanna L Burke; Peter Maramaldi; Tamara Cadet; Walter Kukull
Journal:  Int J Geriatr Psychiatry       Date:  2017-05-31       Impact factor: 3.485

7.  Cortisol, HDL-c, VLDL-c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia.

Authors:  Vivian P Lara; Paulo Caramelli; Antônio L Teixeira; Maira T Barbosa; Karoline C Carmona; Henrique C Guimarães; Maria G Carvalho; Ana P Fernandes; Karina B Gomes
Journal:  J Clin Lab Anal       Date:  2015-08-24       Impact factor: 2.352

8.  Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia.

Authors:  Shanna L Burke; Peter Maramaldi; Tamara Cadet; Walter Kukull
Journal:  Int Psychogeriatr       Date:  2016-03-29       Impact factor: 3.878

9.  The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease.

Authors:  Craig W Ritchie; Karen Ritchie
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

Review 10.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.